What is Citius Pharmaceuticals, Inc.'s stock symbol?

Our stock is traded on the Nasdaq under the symbol CTXR.

back to top

When was Citius Pharmaceuticals, Inc. incorporated?

2010

back to top

When did Citius Pharmaceuticals, Inc. become a public company?

September 2014

back to top

When did Citius acquire Leonard Meron Biosciences (LMB)?

On March 30, 2016, Citius acquired Leonard-Meron Biosciences, Inc. (“LMB”) as a wholly-owned subsidiary. The Company acquired all of the outstanding stock of LMB by issuing shares of its common stock.

back to top

When did Citius form NoveCite Inc.?

On September 11, 2020, Citius formed NoveCite, Inc., a Delaware corporation, of which Citius owns 75% of the issued and outstanding capital stock.

back to top

Where is Citius Pharmaceuticals, Inc. located?

11 Commerce Drive, First Floor
Cranford, NJ 07016

back to top

When is Citius Pharmaceuticals, Inc.'s fiscal year end?

September 30th

back to top

Who is Citius Pharmaceuticals, Inc.'s transfer agent?

VStock Transfer LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
www.vstocktransfer.com

back to top

Who is Citius Pharmaceuticals, Inc.'s independent auditor?

Wolf & Company, P.C.
99 High Street
Boston, MA 02110

back to top

Who is Citius Pharmaceuticals, Inc.'s outside legal counsel?

Wyrick Robbins Yates & Ponton LLP
4101 Lake Boone Trail
Suite 300
Raleigh, NC 27607
www.wyrick.com

back to top

Whom can I contact for general information about Citius Pharmaceuticals, Inc.?

Citius Pharmaceuticals, Inc.
Tel: (908) 967-6677
Email: info@citiuspharma.com

back to top